CombiMatrix Corp (CBMX) - Medical Equipment - Deals and Alliances Profile

Date: July 11, 2017
Pages: 53
Price:
US$ 250.00
License [?]:
Publisher: GlobalData
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: C2BA0678D16EN
Leaflet:

Download PDF Leaflet

CombiMatrix Corp (CBMX) - Medical Equipment - Deals and Alliances Profile
Summary

CombiMatrix Corp (CombiMatrix) is a provider of molecular diagnostic solutions specializing in cytogenomic testing for prenatal diagnosis, miscarriage analysis, and pediatric developmental disorders. It offers DNA-based testing services for the detection of genetic abnormalities. The company provides chromosomal microarray, standardized and customized fluorescence in situ hybridization (FISH) and high-resolution karyotyping. It provides these molecular diagnostic tests based on its array based technologies including Micro Arrays with single nucleotide polymorphism (SNPs) and Micro Arrays with SNPs for formalin-fixed, paraffin-embedded (FFPE) tissue. CombiMatrix is a CAP approved and CLIA-certified molecular diagnostic laboratory. CombiMatrix is headquartered in Irvine, California, the US.

CombiMatrix Corp (CBMX) - Medical Equipment - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.

Scope
  • Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
  • Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
  • Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
  • Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
  • Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
  • Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
  • Business Description - A brief description of the company's operations.
  • Key Employees - A list of the key executives of the company.
  • Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
  • Key Competitors - A list of the key competitors of the company.
  • Key Recent Developments - A brief on recent news about the company.
Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
  • The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion/divestiture strategy
  • The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
  • Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
  • The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
  • Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
  • Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company.
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deal Details
Partnerships
CombiMatrix Enters Into Licensing Agreement With Cartagenia For Benchlab CNV Platform
CombiMatrix Enters into Distribution Agreement with Universal Diagnostic Labs
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests
CombiMatrix Enters Into An Agreement With Clarient
Equity Offering
CombiMatrix Raises USD8 Million in Public Offering of Units
CombiMatrix to Raise USD5 Million in Private Placement of Securities
CombiMatrix to Raise USD3 Million in Private Placement of Warrants
CombiMatrix Completes Public Offering Of Units For US$12 Million
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million
CombiMatrix Completes Private Placement Of Units For US$1.6 Million
CombiMatrix Completes Second Tranche Of Private Placement Of Series A Shares Of Preferred Stock
CombiMatrix Completes Private Placement Of Units For US$7 Million
CombiMatrix Corp - Key Competitors
Key Employees
Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Strategy And Business Planning
Apr 21, 2016: CombiMatrix Provides Strategic Update
Financial Announcements
May 04, 2017: CombiMatrix Reports First Quarter 2017 Financial and Operating Results
Feb 22, 2017: CombiMatrix Reports 2016 Fourth Quarter and Full Year Financial and Operating Results
Nov 02, 2016: CombiMatrix Reports Third Quarter 2016 Financial and Operating Results
Aug 03, 2016: CombiMatrix Reports Second Quarter 2016 Financial and Operating Results
May 04, 2016: CombiMatrix Reports First Quarter 2016 Financial and Operating Results
Feb 17, 2016: CombiMatrix Reports 2015 Fourth Quarter and Full Year Financial and Operating Results
Corporate Communications
Mar 01, 2017: CombiMatrix Appoints Molecular Diagnostics Veteran Dirk van den Boom, Ph.D. to its Board of Directors
Feb 02, 2017: CombiMatrix Appoints Preeminent Pediatric Neurologist Dr. James W. Wheless to its Scientific Advisory Board
Feb 26, 2016: CombiMatrix Forms Scientific Advisory Board; Includes Leaders in Reproductive Health, Pathology, Genetics, Molecular Biology and Health Policy
Feb 11, 2016: CombiMatrix Comments on Revised Reimbursement Policies for Recurrent Pregnancy Loss
Legal and Regulatory
Feb 17, 2016: CombiMatrix Regains Compliance With NASDAQ Minimum Bid Price Listing Requirement
Product News
Jan 20, 2017: CombiMatrix to Present Large-Scale Study Indicating the Severity of Genomic Abnormalities Decreases from Conception to Childhood at the 2nd Congress on Recurrent Pregnancy Loss
Jun 01, 2016: CombiMatrix Launches Next Generation Sequencing for Pre-Implementation Genetic Screening
Feb 09, 2016: CombiMatrix Migrates Miscarriage Analysis Microarray Testing to Newer Scanning Panel
Feb 01, 2016: CombiMatrix Study Published in Genetics in Medicine
Jan 28, 2016: CombiMatrix Announces Commercial Launch of Microarray Testing for Stillbirth Analysis
Other Significant Developments
Mar 23, 2016: ACOG and SMFM Update Practice Bulletins Recommending Prenatal Genetic Assessment for All Pregnant Women Regardless of Age or Other Risk Factors
Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

LIST OF TABLES

CombiMatrix Corp, Medical Equipment, Key Facts, 2016
CombiMatrix Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment Deals By Type, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
CombiMatrix Corp, Deals By Market, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals Summary, 2011 to YTD 2017
CombiMatrix Enters Into Licensing Agreement With Cartagenia For Benchlab CNV Platform
CombiMatrix Enters into Distribution Agreement with Universal Diagnostic Labs
Sequenom And CombiMatrix Enter Into Agreement To Market Chromosomal Microarray Analysis For Prenatal Testing
CombiMatrix Expands Co-Marketing Agreement With Pathology For Prenatal Tests
CombiMatrix Enters Into Co-Marketing Agreement With Pathology For Prenatal Tests
CombiMatrix Enters Into An Agreement With Clarient
CombiMatrix Raises USD8 Million in Public Offering of Units
CombiMatrix to Raise USD5 Million in Private Placement of Securities
CombiMatrix to Raise USD3 Million in Private Placement of Warrants
CombiMatrix Completes Public Offering Of Units For US$12 Million
CombiMatrix Completes Second Tranche Of Private Placement Of Preferred Shares For US$1.2 Million
CombiMatrix Completes Private Placement Of Common Stock For US$0.4 Million
CombiMatrix Completes Private Placement Of Units For US$1.6 Million
CombiMatrix Completes Second Tranche Of Private Placement Of Series A Shares Of Preferred Stock
CombiMatrix Completes Private Placement Of Units For US$7 Million
CombiMatrix Corp, Key Competitors
CombiMatrix Corp, Key Employees
CombiMatrix Corp, Subsidiaries

LIST OF FIGURES

CombiMatrix Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Market, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Year, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals by Type, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals By Region, 2011 to YTD 2017
CombiMatrix Corp, Medical Equipment, Deals by Market, 2011 to YTD 2017
Skip to top


Ask Your Question

CombiMatrix Corp (CBMX) - Medical Equipment - Deals and Alliances Profile
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: